Characterization of 125I-IABN, a novel a
✍
Robert R. Luedtke; Rebekah A. Freeman; Virginia A. Boundy; Michael W. Martin; Yu
📂
Article
📅
2000
🏛
John Wiley and Sons
🌐
English
⚖ 200 KB
👁 2 views
The properties of an (125)I-labeled structural analog of 2, 3-dimethoxy-N-[9-(4-fluorobenzyl)-9-azabicyclo[3.3. 1]nonan-3beta-yl]benzamide (MABN), (125)I-IABN, are described. (125)I-IABN was developed as a high-affinity radioligand selective for the D2-like (D2, D3, and D4) dopamine receptor subtype